<DOC>
	<DOCNO>NCT02401139</DOCNO>
	<brief_summary>This study Randomized Controlled Trial , investigate safety efficacy administration ketamine potential treatment depression .</brief_summary>
	<brief_title>Ketamine Trial Treatment Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Individuals eligible enrolment basis : major depressive disorder least three month duration inadequate response least 2 adequate antidepressant MADRS â‰¥ 20 Patients excluded basis : History psychosis History bipolar disorder Any unstable medical neurologic condition Any Axis I disorder MDD judge primary presenting problem Planned major change psychotropic medication Significant risk suicide Planned probable use ECT Age 16 year , 1617 year without parental consent Substance abuse dependence previous 6 month Any history abuse ketamine phencyclidine Contraindication use ketamine Planned use ketamine Women childbearing potential take reliable contraception Likely noncompliance trial treatment Other condition judge treat clinician likely impact ability participant complete trial</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>